These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 19452709)

  • 1. [Clinical research of Ibudilast on treating the steroid resistant allergic rhinitis].
    Luo H; Tao Z; Yan N; Liang J; Wang P; Wang J
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2009 Jan; 23(2):63-6. PubMed ID: 19452709
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [In seasonal and perennial rhinitis. Superiority to standard H1 blockers].
    MMW Fortschr Med; 2003 May; 145(22):51. PubMed ID: 12866281
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparison of the combinations of fexofenadine-pseudoephedrine and loratadine-montelukast in the treatment of seasonal allergic rhinitis.
    Moinuddin R; deTineo M; Maleckar B; Naclerio RM; Baroody FM
    Ann Allergy Asthma Immunol; 2004 Jan; 92(1):73-9. PubMed ID: 14756468
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Concomitant montelukast and loratadine as treatment for seasonal allergic rhinitis: a randomized, placebo-controlled clinical trial.
    Meltzer EO; Malmstrom K; Lu S; Prenner BM; Wei LX; Weinstein SF; Wolfe JD; Reiss TF
    J Allergy Clin Immunol; 2000 May; 105(5):917-22. PubMed ID: 10808172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Nasal budesonide plus zafirlukast vs nasal budesonide plus loratadine-pseudoephedrine for controlling the symptoms of rhinitis and asthma].
    Benitez HH; Arvizu VM; Gutiérrez DJ; Fogelbach GA; Castellanos Olivares A; Vázquez Nava F; Velázquez HC; González Pérez Mdel C; Mora Nieto A; Rodríguez EC
    Rev Alerg Mex; 2005; 52(2):90-5. PubMed ID: 16158782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Antihistaminics. Side effects also after raising dosage at the placebo level].
    MMW Fortschr Med; 2003 May; 145(22):50-1. PubMed ID: 12866280
    [No Abstract]   [Full Text] [Related]  

  • 7. [Observation on cardiovascular safety of loratadine in treatment of persistent allergic rhinitis].
    Liu Y; Cheng L
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2008 Dec; 22(23):1076-8. PubMed ID: 19253533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Desloratadine for allergic rhinitis.
    See S
    Am Fam Physician; 2003 Nov; 68(10):2015-6. PubMed ID: 14655812
    [No Abstract]   [Full Text] [Related]  

  • 9. Fluticasone nasal spray and the combination of loratadine and montelukast in seasonal allergic rhinitis.
    Saengpanich S; deTineo M; Naclerio RM; Baroody FM
    Arch Otolaryngol Head Neck Surg; 2003 May; 129(5):557-62. PubMed ID: 12759270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cetirizine, loratadine, or placebo in subjects with seasonal allergic rhinitis: effects after controlled ragweed pollen challenge in an environmental exposure unit.
    Day JH; Briscoe M; Widlitz MD
    J Allergy Clin Immunol; 1998 May; 101(5):638-45. PubMed ID: 9600501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nasal saline: placebo or drug?
    Uras N; Karadag A; Kurtaran H; Yilmaz T
    Ann Allergy Asthma Immunol; 2004 Jul; 93(1):104; author reply 104. PubMed ID: 15281480
    [No Abstract]   [Full Text] [Related]  

  • 12. [The effect of antianaphylaxis drugs on specific IgE and eosinophil in serum of patients with allergic rhinitis].
    Liu X; Xing Z; Gao Z
    Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2005 Apr; 19(8):337-9. PubMed ID: 16075981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and tolerability of montelukast alone or in combination with loratadine in seasonal allergic rhinitis: a multicenter, randomized, double-blind, placebo-controlled trial performed in the fall.
    Nayak AS; Philip G; Lu S; Malice MP; Reiss TF;
    Ann Allergy Asthma Immunol; 2002 Jun; 88(6):592-600. PubMed ID: 12086367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Nasal obstruction on the decline. Antihistamine allows allergic patients to breathe].
    MMW Fortschr Med; 2004 Jul; 146(27-28):52. PubMed ID: 15526672
    [No Abstract]   [Full Text] [Related]  

  • 15. Pharmacotherapy for allergic rhinitis: a critical review of leukotriene receptor antagonists compared with other treatments.
    Nathan RA
    Ann Allergy Asthma Immunol; 2003 Feb; 90(2):182-90; quiz 190-1, 232. PubMed ID: 12602664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Oral second generation antihistamines in allergic rhinitis].
    Riechelmann H
    Laryngorhinootologie; 2005 Jan; 84(1):30-41. PubMed ID: 15647976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of allergic rhinitis in infants and children: efficacy and safety of second-generation antihistamines and the leukotriene receptor antagonist montelukast.
    Phan H; Moeller ML; Nahata MC
    Drugs; 2009; 69(18):2541-76. PubMed ID: 19943707
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The investigation of efficacy and safety of Aerius to seasonal allergic rhinitis].
    You X; Liu Z; Xu K; Gao Q; Cui Y
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2008 Apr; 22(8):382-4. PubMed ID: 18595523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Respiratory allergies in the child and the adult].
    Magnan A
    Rev Prat; 2004 Jan; 54(2):189-98. PubMed ID: 15086062
    [No Abstract]   [Full Text] [Related]  

  • 20. Mizolastine provides effective symptom relief in patients suffering from perennial allergic rhinitis: a double-blind, placebo-controlled study versus loratadine.
    Frèche C; Leynadier F; Horak F; Hide D; Gracia FD; Goos M; Bachert C; Horvath A; Antosova E; Verrecchia M; Soussen PB
    Ann Allergy Asthma Immunol; 2002 Sep; 89(3):304-10. PubMed ID: 12269652
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.